Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.

作者: Guillaume Moulis , Laurent Sailler , Agnès Sommet , Maryse Lapeyre-Mestre , Jean-Louis Montastruc

DOI: 10.1002/PDS.2253

关键词:

摘要: Purpose Risk factors for intravenous immunoglobulin-induced renal failure (IVIg-RF) were suspected from case series studies. This study was aimed at quantifying the risk of IVIg-RF associated with exposure to drugs that modify intrarenal hemodynamics. Methods We conducted a case–control in French Pharmacovigilance Database (FPVD). Adult cases registered FPVD 1996 2009 reviewed. Controls patients included another IVIg adverse effect. matched sucrose content preparation, year event and age. The predictors angiotensin-converting enzyme inhibitors (ACE-I), angiotensin receptor antagonists (ARA), diuretics, age, gender weight, delivered dose infusion duration, chronic kidney disease, hypertension diabetes mellitus. Acute defined as calculated creatinine clearance less than 60 mL/min and, (i) more 50% increase serum creatinine, (ii) an indication oligo-anuria or (iii) requirement dialysis. Results We selected 71 controls. Forty-nine percent required transient hemodialysis. In final multivariate model, ACE-I and/or ARA sole independent predictor (OR = 7.9, 95%CI = 1.3–49.2). There interaction between ‘diabetes mellitus’ (OR = 7.7, 95%CI = 2.3–25.5) ‘chronic disease’ (OR = 13.0, 95%CI = 3.1–54.7), both being strong univariate models (p < 0.001). Chronic factor hemodialysis. Conclusions Temporary interruption may be considered time infusion. Copyright © 2011 John Wiley & Sons, Ltd.

参考文章(19)
F Peyrade, C Passeron, B Taillan, P Dujardin, Insuffisance rénale aiguë aux immunoglobulines Revue de Médecine Interne. ,vol. 19, pp. 746- 747 ,(1998) , 10.1016/S0248-8663(98)80714-5
T. H. Brannagan, K. J. Nagle, D. J. Lange, L. P. Rowland, Complications of intravenous immune globulin treatment in neurologic disease. Neurology. ,vol. 47, pp. 674- 677 ,(1996) , 10.1212/WNL.47.3.674
Hedi Orbach, Moshe Tishler, Yehuda Shoenfeld, Intravenous immunoglobulin and the kidney--a two-edged sword. Seminars in Arthritis and Rheumatism. ,vol. 34, pp. 593- 601 ,(2004) , 10.1016/J.SEMARTHRIT.2004.06.003
Mustafa Cirit, Omer Toprak, Murat Yesil, Serdar Bayata, Nursen Postaci, Lara Pupim, Ertap Esi, Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clinical Practice. ,vol. 104, ,(2006) , 10.1159/000093255
Hedi Orbach, Uriel Katz, Yaniv Sherer, Yehuda Shoenfeld, Intravenous immunoglobulin: adverse effects and safe administration. Clinical Reviews in Allergy & Immunology. ,vol. 29, pp. 173- 184 ,(2005) , 10.1385/CRIAI:29:3:173
Jordan L. Rosenstock, Robert Bruno, Jin K. Kim, Lev Lubarsky, Robert Schaller, Georgia Panagopoulos, Maria V. DeVita, Michael F. Michelis, The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy International Urology and Nephrology. ,vol. 40, pp. 749- 755 ,(2008) , 10.1007/S11255-008-9368-1
George Dangas, Ioannis Iakovou, Eugenia Nikolsky, Eve D. Aymong, Gary S. Mintz, Nicholas N. Kipshidze, Alexandra J. Lansky, Issam Moussa, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, Roxana Mehran, Contrast-Induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables American Journal of Cardiology. ,vol. 95, pp. 13- 19 ,(2005) , 10.1016/J.AMJCARD.2004.08.056
Michael L. Bentley, Howard L. Corwin, Joseph Dasta, Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies. Critical Care Medicine. ,vol. 38, ,(2010) , 10.1097/CCM.0B013E3181DE0C60
H. I. A. Sati, R. Ahya, H. G. Watson, Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy. British Journal of Haematology. ,vol. 113, pp. 556- 557 ,(2001) , 10.1046/J.1365-2141.2001.02742.X
Pradeep Arora, Srini Rajagopalam, Rajiv Ranjan, Hari Kolli, Manpreet Singh, Rocco Venuto, James Lohr, Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clinical Journal of The American Society of Nephrology. ,vol. 3, pp. 1266- 1273 ,(2008) , 10.2215/CJN.05271107